An albumin-binding domain and targeting peptide-based recombinant protein and its enediyne-integrated analogue exhibit directional delivery and potent inhibitory activity on pancreatic cancer with K-ras mutation.
- Resource Type
- Article
- Source
- Oncology Reports; Mar2020, Vol. 43 Issue 3, p851-863, 13p
- Subject
- Language
- ISSN
- 1021335X